메뉴 건너뛰기




Volumn 60, Issue 13-14, 1997, Pages 969-976

In vivo pharmacology of butylthio[2.2.2](LY297802/NNC11-1053), and orally acting antinociceptive muscarinic agonist

Author keywords

antinociception; butylthio 2.2.2 ; M2 antagonist

Indexed keywords

3 (4 BUTYLTHIO 1,2,5 THIADIAZOL 3 YL)QUINUCLIDINE; 3 [4 BUTYLTHIO 1,2,5 THIADIAZOL 3 YL] 1 AZABICYCLO[2.2.2]OCTANE; ANALGESIC AGENT; ARECOLINE DERIVATIVE; MORPHINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER RECEPTOR; OXOTREMORINE M; PIRENZEPINE; QUINUCLIDINYL BENZILATE; RADIOLIGAND; RECEPTOR SUBTYPE; SCOPOLAMINE; UNCLASSIFIED DRUG;

EID: 0030984542     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00036-2     Document Type: Conference Paper
Times cited : (20)

References (24)
  • 12
    • 0024504193 scopus 로고
    • P.J. BARNES, Thorax 44 161-167 (1989).
    • (1989) Thorax , vol.44 , pp. 161-167
    • Barnes, P.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.